MAPT and Alzheimer disease: Using a locally estimated scatterplot smoothing (LOESS), we also modelled the cross-sectional pseudo-trajectories of the studied CSF tau biomarkers using tau-PET (medial temporal and neocortical SUVR) as a proxy of tau pathology progression in AD (Fig. 1; individual associations are presented on Supplementary Figure S4).